GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (MEX:0QBO) » Definitions » Cyclically Adjusted Price-to-FCF

Coloplast A/S (MEX:0QBO) Cyclically Adjusted Price-to-FCF : 58.68 (As of Jun. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted Price-to-FCF?

As of today (2024-06-21), Coloplast A/S's current share price is MXN2082.59. Coloplast A/S's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was MXN35.49. Coloplast A/S's Cyclically Adjusted Price-to-FCF for today is 58.68.

The historical rank and industry rank for Coloplast A/S's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MEX:0QBO' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 41.66   Med: 58.99   Max: 86.54
Current: 53.59

During the past years, Coloplast A/S's highest Cyclically Adjusted Price-to-FCF was 86.54. The lowest was 41.66. And the median was 58.99.

MEX:0QBO's Cyclically Adjusted Price-to-FCF is ranked worse than
63.56% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 41.72 vs MEX:0QBO: 53.59

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Coloplast A/S's adjusted free cash flow per share data for the three months ended in Mar. 2024 was MXN-30.514. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is MXN35.49 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted Price-to-FCF Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.24 72.94 68.89 46.43 44.66

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.19 51.70 44.66 45.24 58.68

Competitive Comparison of Coloplast A/S's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted Price-to-FCF falls into.



Coloplast A/S Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Coloplast A/S's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=2082.59/35.49
=58.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Coloplast A/S's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-30.514/118.4000*118.4000
=-30.514

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 9.388 99.700 11.149
201409 10.913 99.700 12.960
201412 5.654 99.400 6.735
201503 0.466 100.200 0.551
201506 10.757 100.300 12.698
201509 14.529 100.200 17.168
201512 5.944 99.800 7.052
201603 4.377 100.200 5.172
201606 5.899 100.600 6.943
201609 14.621 100.200 17.277
201612 1.957 100.300 2.310
201703 1.961 101.200 2.294
201706 12.205 101.200 14.279
201709 18.003 101.800 20.939
201712 11.910 101.300 13.920
201803 3.969 101.700 4.621
201806 17.066 102.300 19.752
201809 19.645 102.400 22.715
201812 9.025 102.100 10.466
201903 4.399 102.900 5.062
201906 16.550 102.900 19.043
201909 21.127 102.900 24.309
201912 10.615 102.900 12.214
202003 5.853 103.300 6.709
202006 19.855 103.200 22.779
202009 23.744 103.500 27.162
202012 -0.275 103.400 -0.315
202103 7.948 104.300 9.022
202106 17.481 105.000 19.712
202109 25.453 105.800 28.484
202112 13.594 106.600 15.099
202203 -0.263 109.900 -0.283
202206 17.665 113.600 18.411
202209 21.914 116.400 22.291
202212 2.771 115.900 2.831
202303 4.858 117.300 4.904
202306 10.298 116.400 10.475
202309 16.607 117.400 16.748
202312 17.186 116.700 17.436
202403 -30.514 118.400 -30.514

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (MEX:0QBO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Coloplast A/S Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (MEX:0QBO) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (MEX:0QBO) Headlines

No Headlines